GlucoTrack, Inc. (GCTK)
0.4032
-0.20
(-32.67%)
USD |
NASDAQ |
Oct 23, 16:00
0.42
+0.02
(+4.17%)
After-Hours: 20:00
GlucoTrack Enterprise Value : 1.003M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.003M |
| October 22, 2026 | 1.085M |
| October 21, 2026 | 1.102M |
| October 20, 2026 | 1.107M |
| October 19, 2026 | 1.121M |
| October 16, 2026 | 1.138M |
| October 15, 2026 | 1.182M |
| October 14, 2026 | 1.205M |
| October 13, 2026 | 1.298M |
| October 12, 2026 | 1.319M |
| October 09, 2026 | 1.265M |
| October 08, 2026 | 1.298M |
| October 07, 2026 | 1.315M |
| October 06, 2026 | 1.306M |
| October 05, 2026 | 1.298M |
| October 02, 2026 | 1.340M |
| October 01, 2026 | 1.423M |
| September 30, 2026 | 1.519M |
| September 29, 2026 | 1.561M |
| September 28, 2026 | 1.586M |
| September 25, 2026 | 1.594M |
| September 24, 2026 | 1.912M |
| September 23, 2026 | 1.682M |
| September 22, 2026 | 1.761M |
| September 21, 2026 | 1.795M |
| Date | Value |
|---|---|
| September 18, 2026 | 1.866M |
| September 17, 2026 | 1.828M |
| September 16, 2026 | 1.772M |
| September 15, 2026 | 1.782M |
| September 14, 2026 | 1.857M |
| September 11, 2026 | 1.899M |
| September 10, 2026 | 2.183M |
| September 09, 2026 | 2.145M |
| September 08, 2026 | 2.058M |
| September 04, 2026 | 2.079M |
| September 03, 2026 | 2.220M |
| September 02, 2026 | 2.308M |
| September 01, 2026 | 2.371M |
| August 31, 2026 | 2.608M |
| August 28, 2026 | 2.600M |
| August 27, 2026 | 2.626M |
| August 26, 2026 | 2.845M |
| August 25, 2026 | 2.964M |
| August 24, 2026 | 2.916M |
| August 21, 2026 | 3.010M |
| August 20, 2026 | 2.973M |
| August 19, 2026 | 3.018M |
| August 18, 2026 | 2.994M |
| August 17, 2026 | 2.976M |
| August 14, 2026 | 3.135M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nuwellis, Inc. | -3.527M |
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.814M |
| Total Expenses (Quarterly) | 3.814M |
| EPS Diluted (Quarterly) | -11.42 |
| Earnings Yield | -44.75K% |
| Normalized Earnings Yield | -44755.83 |